Alzheimer's disease - challenges for the future / / edited by Inga Zerr.
There is a wide scope of clinical phenomenology in Alzheimers disease, regarding the age of onset, presenting features, rate of progression and appearance of other clinical manifestation. Although clinical appearance and neuropathological hallmarks have been defining AD since its first description,...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | [Place of publication not identified] : : IntechOpen,, [2015] ©2015 |
Year of Publication: | 2015 |
Language: | English |
Physical Description: | 1 online resource (372 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545902404498 |
---|---|
ctrlnum |
(CKB)4970000000098898 (NjHacI)994970000000098898 (oapen)https://directory.doabooks.org/handle/20.500.12854/66707 (EXLCZ)994970000000098898 |
collection |
bib_alma |
record_format |
marc |
spelling |
Zerr, Inga edt Alzheimer's disease - challenges for the future / edited by Inga Zerr. Alzheimer's disease Alzheimer's Disease â Challenges for the Future IntechOpen 2015 [Place of publication not identified] : IntechOpen, [2015] ©2015 1 online resource (372 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on print version record. Open access Unrestricted online access star There is a wide scope of clinical phenomenology in Alzheimers disease, regarding the age of onset, presenting features, rate of progression and appearance of other clinical manifestation. Although clinical appearance and neuropathological hallmarks have been defining AD since its first description, major factors which trigger pathology are still unknown. The role of comorbidity is discussed controversially. Important environmental risk factors in AD development are continuous stress, low education and cardiovascular risk factors such as alcohol intake, smoking, hypertension. The role of lipids and cholesterol has been recognized, but the relevant pathogenetic steps are still to be identified. There is an urgent need to understand molecular disease pathogenesis in order to develop early therapeutic targets for the disease. English Alzheimer's disease. Neurology & clinical neurophysiology 953-51-2137-5 Zerr, Inga, editor. |
language |
English |
format |
eBook |
author2 |
Zerr, Inga, |
author_facet |
Zerr, Inga, |
author2_variant |
i z iz i z iz |
author2_role |
TeilnehmendeR |
title |
Alzheimer's disease - challenges for the future / |
spellingShingle |
Alzheimer's disease - challenges for the future / |
title_full |
Alzheimer's disease - challenges for the future / edited by Inga Zerr. |
title_fullStr |
Alzheimer's disease - challenges for the future / edited by Inga Zerr. |
title_full_unstemmed |
Alzheimer's disease - challenges for the future / edited by Inga Zerr. |
title_auth |
Alzheimer's disease - challenges for the future / |
title_alt |
Alzheimer's disease Alzheimer's Disease â Challenges for the Future |
title_new |
Alzheimer's disease - challenges for the future / |
title_sort |
alzheimer's disease - challenges for the future / |
publisher |
IntechOpen IntechOpen, |
publishDate |
2015 |
physical |
1 online resource (372 pages) |
isbn |
953-51-7242-5 953-51-2137-5 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC523 |
callnumber-sort |
RC 3523 A494 42015 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.831 |
dewey-sort |
3616.831 |
dewey-raw |
616.831 |
dewey-search |
616.831 |
work_keys_str_mv |
AT zerringa alzheimersdiseasechallengesforthefuture AT zerringa alzheimersdisease AT zerringa alzheimersdiseaseachallengesforthefuture |
status_str |
n |
ids_txt_mv |
(CKB)4970000000098898 (NjHacI)994970000000098898 (oapen)https://directory.doabooks.org/handle/20.500.12854/66707 (EXLCZ)994970000000098898 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Alzheimer's disease - challenges for the future / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1787548726649159680 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02217nam a2200421 i 4500</leader><controlfield tag="001">993545902404498</controlfield><controlfield tag="005">20231108172645.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr#|||||||||||</controlfield><controlfield tag="008">221006s2015 xx o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-7242-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000098898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000098898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/66707</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000098898</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC523</subfield><subfield code="b">.A494 2015</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.831</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zerr, Inga</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Alzheimer's disease - challenges for the future /</subfield><subfield code="c">edited by Inga Zerr.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Alzheimer's disease</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Alzheimer's Disease â Challenges for the Future</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2015</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Place of publication not identified] :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2015]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (372 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on print version record.</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">There is a wide scope of clinical phenomenology in Alzheimers disease, regarding the age of onset, presenting features, rate of progression and appearance of other clinical manifestation. Although clinical appearance and neuropathological hallmarks have been defining AD since its first description, major factors which trigger pathology are still unknown. The role of comorbidity is discussed controversially. Important environmental risk factors in AD development are continuous stress, low education and cardiovascular risk factors such as alcohol intake, smoking, hypertension. The role of lipids and cholesterol has been recognized, but the relevant pathogenetic steps are still to be identified. There is an urgent need to understand molecular disease pathogenesis in order to develop early therapeutic targets for the disease.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Alzheimer's disease.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Neurology & clinical neurophysiology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-51-2137-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zerr, Inga,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-11-09 11:42:51 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338043240004498&Force_direct=true</subfield><subfield code="Z">5338043240004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338043240004498</subfield></datafield></record></collection> |